Printer Friendly

Chronic Inflammation
and Autoimmunity


Main Goal

To understand the factors that play a central role in chronic inflammation and autoimmunity and identify potential targets for developing therapeutic agents.

Specific Objectives

  • Understand the mechanism/s action of CD28:CD152/CD80:CD86, the major T cell costimulatory pathway.

  • Integrate the structural and functional knowledge of the individual members of the above pathway in identifying specific sites of interaction(s).

  • Develop strategies to transfer the potential sites of interaction/s onto small molecules.

  • Characterizing the structural, functional and therapeutic potential of the small molecules.

Program Director:

Dr. Mythily Srinivasan

Other Faculty Supporting the Program:

Dr. Janice Blum
Dr. Rajaraman Eri

Licensing and sponsored research opportunities abstract:

Licensing and sponsored research opportunities contact Mark Reichel
For research collaboration contact Dr. Srinivasan

Relevant Publications:

Srinivasan M, Wardrop RM, Whitacre CC, Kaumaya PTP. 1999. A CD28 CDR-3 peptide analog inhibits CD4+ T cell proliferation in vitro. In Fields,G.B., Tam, J.P., Baraby,G. (eds) Peptides for the New Millennnium. Kluwer,Netherlands, 589-90.

Srinivasan M, Gienapp IE, Rogers CC, Whitacre CC, Kaumaya PTP. 2001. Costimulatory blockade by CD28 peptide mimics. In Lebl M., Houghten R.A. (eds) Peptides: The Wave of the Future, San Diego, CA, USA, 654-55.

Srinivasan M, Wardrop RM, Gienapp IE, Stuckman SS, Whitacre CC, Kaumaya PTP 2001. A retro-inverso CD28 peptide encompassing "MYPPPY" adopts a PP II helix and inhibits encephalitogenic T cells in vitro. Journal of Immunology, 67(1) 578-85.

Srinivasan M, Gienapp IE, Stuckman SS, Whitacre CC, Kaumaya PTP 2002.Costimulatory Blockade by CD28 Peptide Mimics. In Lebel m., Houghten R.A. (Eds) Peptides: The Wave of the Future. San Diego, USA. 654-55.

Srinivasan M, Gienapp IE, Stuckman SS, Rogers CC, Kaumaya PTP, Whitacre CC. 2002. Suppression of Experimental Autoimmune Encephalomyelitis by CD28 peptide mimics. Journal of Immunology, 169(4)2180-88.

Srinivasan M., Roeske R (2004).Immunomodulatory peptide antagonists –a review :Current protein and peptide Science.

Srinivasan M, Lu D, Eri R, Haque A, Blum JS (2004). Design, structure and functional characteristics of CD80 binding pseudoreceptor. (Under revision).